Clinical Trial Update: Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study comparing fludarabine plus pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN